Amphastar Pharmaceuticals Inc

AMPH

Company Profile

  • Business description

    Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

  • Contact

    11570 6th Street
    Rancho CucamongaCA91730
    USA

    T: +1 909 980-9484

    https://www.amphastar.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,976

Stocks News & Analysis

stocks

Stop asking if there’s a stock market bubble. Ask this instead.

Why earnings growth might be more important when assessing frothy market conditions.
stocks

Are negative AI narratives holding this ASX share back?

This company is unlikely to be disrupted by AI
stocks

ASX growth share with attractive dividend

Worries about AI overblown.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,986.2049.10-0.54%
CAC 408,378.9611.630.14%
DAX 4024,919.16292.271.19%
Dow JONES (US)52,182.74306.630.59%
FTSE 10010,556.2872.060.69%
HKSE22,881.02145.66-0.63%
NASDAQ25,820.14522.532.07%
Nikkei 22570,062.32594.210.86%
NZX 50 Index13,621.6676.100.56%
S&P 5007,440.430.000.00%
S&P/ASX 2008,778.7052.80-0.60%
SSE Composite Index4,094.4020.500.50%

Market Movers